Janić Tamara | Čigota Zlatibor - specijalna bolnica za bolesti štitaste žlezde i metabolizma

EVALUATION OF RENIN-DEPENDENT ALDOSTERONISM

Ustanova

Clinic for Endocrinology, Diabetes and Metabolic Diseases, University Clinical Center of Serbia

Faculty of Medicine, University of Belgrade, Serbia

Reference

Young WF Jr. Diagnosis and management of primary aldosteronism. In: Feingold KR, Anawalt B, Blackman MR, et al., editors. Endotext [Internet]. South Dartmouth (MA): MDText.com, Inc.; 2000– [updated 2018 Feb 8; cited 2024 Dec 6].

Scott JH, Menouar MA, Dunn RJ. Physiology, Aldosterone. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2024 Jan– [updated 2023 May 1]. PMID: 29261963.

Funder JW, Carey RM, Mantero F, Murad MH, Reincke M, Shibata H, et al. The management of primary aldosteronism: case detection, diagnosis, and treatment: an Endocrine Society Clinical Practice Guideline. J Clin Endocrinol Metab. 2016; 101(5): 1889–916. do

Sažetak

EVALUATION OF RENIN-DEPENDENT ALDOSTERONISM

Jazika rada

Medicinski glasnik

Autor

Read more about EVALUATION OF RENIN-DEPENDENT ALDOSTERONISM

Efficacy of Tocilizumab in Resistant Forms of Thyroid Eye Disease

Ustanova

Clinic for Endocrinology, Diabetes and Metabolic Diseases, University Faculty of Medicine, University of Belgrade, Serbia

Reference

Jacobs D, Galetta S. Diagnosis and management of orbital pseudotumor. Curr Opin Ophthalmol. 2002; 12: 347–51. doi: 10.1097/00055735-200212000-00001.

Lacey B, Chang W, Rootman J. Nonthyroid causes of extraocular muscle disease. Surv Ophthalmol. 1999; 44: 187–213. doi: 10.1016/s0039-6257(99)00101-0.

McKeag D, Lane CM, Lazarus JH, et al. Clinical features of dysthyroid optic neuropathy: a European group on Graves’ Orbitopathy (EUGOGO) survey. Br J Ophthalmol. 2007; 91: 455–8. doi: 10.1136/bjo.2006.094607.

Sažetak

Efficacy of Tocilizumab in Resistant Forms of Thyroid Eye Disease

Jazika rada

Medicinski glasnik

Autor

Read more about Efficacy of Tocilizumab in Resistant Forms of Thyroid Eye Disease

Case Series of Dermopathy in Autoimmune Thyroid Disease

Ustanova

Clinical Center of Endocrinology, Diabetes, and Metabolic Diseases, University Clinical Center of Serbia, Department of Thyroid Diseases

Medical Faculty, University of Belgrade, Serbia

Reference

Fatourechi V, Bartley GB, Eghbali-Fatourechi GZ, Powell CC, Ahmed DD, Garrity JA. Graves’ dermopathy and acropachy are markers of severe Graves’ ophthalmopathy. Thyroid. 2003 Dec;13(12):1141-4.

Fatourechi V, Garrity JA, Bartley GB, Bergstralh EJ, Gorman CA. Orbital decompression in Graves’ ophthalmopathy associated with pretibial myxedema. J Endocrinol Invest. 1993 Jun;16(6):433-7.

Fatourechi V, Pajouhi M, Fransway AF. Dermopathy of Grave’s disease (pretibial myxe- dema). Review of 150 cases. Medicine (Baltimore). 1994; 73:1-7;

Sažetak

Case Series of Dermopathy in Autoimmune Thyroid Disease

Ključne reči

Medicinski glasnik

Autor

Read more about Case Series of Dermopathy in Autoimmune Thyroid Disease

Diagnostic Uncertainty in Primary Aldosteronism

Ustanova

Clinic of Endocrinology, Diabetes, and Metabolic Diseases, University Clinical Center of Serbia, Faculty of Medicine, University of Belgrade.

Faculty of Medicine, University of Belgrade, Belgrade.

Reference

Scott JH, Menouar MA, Dunn RJ. Physiology, Aldosterone. 2023 May 1. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2024 Jan–. PMID: 29261963

Funder JW, Carey RM, Mantero F, Murad MH, Reincke M, Shibata H, et al. The mana- gement of primary aldosteronism: case detection, diagnosis, and treatment: an Endocrine Society Clinical Practice Guideline. J Clin Endocrinol Metab. 2016; 101(5):1889-916. d

Sažetak

Diagnostic Uncertainty in Primary Aldosteronism

Ključne reči

secondary hypertension

Medicinski glasnik

Autor

Read more about Diagnostic Uncertainty in Primary Aldosteronism

Steroid-Resistant Graves’ Orbitopathy – therapeutic options

Ustanova

Clinic of Endocrinology, Diabetes and Metabolic Disease, University Clinical Center of Serbia

Faculty of Medicine, University of Belgrade

Reference

Bartalena L, Piantanida E, Gallo D, Lai A, Tanda ML. Epidemiology, Natural History, Risk Factors, and Prevention of Graves’ Orbitopathy. Front Endocrinol (Lausanne). 2020; 11: 1.

Men CJ, Kossler AL, Wester ST. Updates on the understanding and management of thyroid eye disease. Ther Adv Ophthalmol 2021; 13: 1–14. Kortokorezistentna Grejvsova orbitopatija – terapijske opcije 83

Tsui S, Naik V, Hoa N, Hwang CJ, Afifiyan NF, Sinha Hikim A, Gianoukakis AG, Douglas RS, Smith TJ. Evidence for an association between thyroid-stimulating hormone and insulin-like growth factor 1 receptors: a tale of two antigens implicated in Graves’ dis

Sažetak

Steroid-Resistant Graves’ Orbitopathy – therapeutic options

Ključne reči

Graves’ orbitopathy

corticosteroid-resistant Graves’ orbitopathy

Medicinski glasnik

Autor

Read more about Steroid-Resistant Graves’ Orbitopathy – therapeutic options

Calcitonin values in pseudohypoparathyroidism

Ustanova

Clinic for Endocrinology, Diabetes and Metabolic Diseases, University Clinical Center of Serbia, Department of Thyroid Diseases

Faculty of Medicine, University of Belgrade, Serbia

Sažetak

Calcitonin values in pseudohypoparathyroidism

Ključne reči

pseudohypoparathyroidism

Medicinski glasnik

Autor

Read more about Calcitonin values in pseudohypoparathyroidism

Aggressive clinical course of medullary thyroid microcarcinoma

Ustanova

Clinic of Endocrinology, Diabetes and Metabolic Disease, University Clinical Center of Serbia

Faculty of medicine, University of Belgrade

Reference

Hundahl SA, Cady B, Cunningham MP, et al. Initial results from a prospective cohort study of 5583 cases of thyroid carcinoma treated in the united states during 1996. US and German Thyroid Cancer Study Group An American College of Surgeons Commission on C

Perry A, Molberg K, Albores-Saavedra J. Physiologic versus neoplastic C-cell hyperplasia of the thyroid: separation of distinct histologic and biologic entities. Cancer 1996; 77: 750–756.

Albores-Saavedra, J., Krueger, J. E. C-Cell hyperplasia and medullary thyroid microcarcinoma. Endocr Pathol 12, 365–377 (2001). https://doi.org/10.1385/EP:12:4:365

Sažetak

Aggressive clinical course of medullary thyroid microcarcinoma

Ključne reči

Medullary thyroid carcinoma

C-cell hyperplasia

aggressive disease course

metastases

calcium stimulation test

tyrosine kinase inhibitors

calcitonin

carcinoembryonic antigen

Medicinski glasnik

Autor

Read more about Aggressive clinical course of medullary thyroid microcarcinoma

Image-guided methods in the treatment of thyroid nodules and cancer

Ustanova

Clinic of Endocrinology, Diabetes and Metabolic Disease, University Clinical Center of Serbia.

Faculty of Medicine, University of Belgrade

Reference

Ezzat S, Sarti DA, Cain DR, Braunstein GD. Thyroid incidentalomas. Prevalence by palpation and ultrasonography. Arch Intern Med. 1994 Aug 22; 154(16): 1838–40.

Mazzaferri EL. Management of a Solitary Thyroid Nodule. New England Journal of Medicine. 1993 Feb 25; 328(8): 553–9.

Ahn HS, Kim HJ, Welch HG. Korea’s Thyroid-Cancer “Epidemic” — Screening and Overdiagnosis. New England Journal of Medicine. 2014 Nov 6; 371(19): 1765–7.

Sažetak

Image-guided methods in the treatment of thyroid nodules and cancer

Medicinski glasnik

Autor

Read more about Image-guided methods in the treatment of thyroid nodules and cancer